Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability OutcomesGrace Chen, Emily E. Coates, Sarah H. Plummer et al.|JAMA|2020Cited by 109
High burden of sexually transmitted infections among under-resourced populations in the Dominican RepublicSilvia Amesty, Barbara S. Taylor, Rafael Pérez‐Figueroa et al.|Therapeutic Advances in Infectious Disease|2023Cited by 5
Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particlesPaul Goepfert, Harriet L. Robinson, Georgia D. Tomaras et al.|Retrovirology|2012Cited by 1